JP2009544698A5 - - Google Patents

Download PDF

Info

Publication number
JP2009544698A5
JP2009544698A5 JP2009521759A JP2009521759A JP2009544698A5 JP 2009544698 A5 JP2009544698 A5 JP 2009544698A5 JP 2009521759 A JP2009521759 A JP 2009521759A JP 2009521759 A JP2009521759 A JP 2009521759A JP 2009544698 A5 JP2009544698 A5 JP 2009544698A5
Authority
JP
Japan
Prior art keywords
use according
polynucleotide
viral vector
vector
coronary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009521759A
Other languages
English (en)
Japanese (ja)
Other versions
JP5623740B2 (ja
JP2009544698A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/016129 external-priority patent/WO2008013692A2/en
Publication of JP2009544698A publication Critical patent/JP2009544698A/ja
Publication of JP2009544698A5 publication Critical patent/JP2009544698A5/ja
Application granted granted Critical
Publication of JP5623740B2 publication Critical patent/JP5623740B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009521759A 2006-07-25 2007-07-16 遺伝子治療用アデノ随伴ウイルスベクターの長期順行性の心外膜冠動脈注入 Active JP5623740B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83332406P 2006-07-25 2006-07-25
US60/833,324 2006-07-25
PCT/US2007/016129 WO2008013692A2 (en) 2006-07-25 2007-07-16 Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014156560A Division JP2014218509A (ja) 2006-07-25 2014-07-31 遺伝子治療用アデノ随伴ウイルスベクターの長期順行性の心外膜冠動脈注入

Publications (3)

Publication Number Publication Date
JP2009544698A JP2009544698A (ja) 2009-12-17
JP2009544698A5 true JP2009544698A5 (cg-RX-API-DMAC7.html) 2010-09-02
JP5623740B2 JP5623740B2 (ja) 2014-11-12

Family

ID=38581949

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009521759A Active JP5623740B2 (ja) 2006-07-25 2007-07-16 遺伝子治療用アデノ随伴ウイルスベクターの長期順行性の心外膜冠動脈注入
JP2014156560A Pending JP2014218509A (ja) 2006-07-25 2014-07-31 遺伝子治療用アデノ随伴ウイルスベクターの長期順行性の心外膜冠動脈注入

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014156560A Pending JP2014218509A (ja) 2006-07-25 2014-07-31 遺伝子治療用アデノ随伴ウイルスベクターの長期順行性の心外膜冠動脈注入

Country Status (13)

Country Link
US (2) US20080076730A1 (cg-RX-API-DMAC7.html)
EP (2) EP2044199B1 (cg-RX-API-DMAC7.html)
JP (2) JP5623740B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090035711A (cg-RX-API-DMAC7.html)
CN (1) CN101495627A (cg-RX-API-DMAC7.html)
AU (1) AU2007277392A1 (cg-RX-API-DMAC7.html)
CA (1) CA2658628A1 (cg-RX-API-DMAC7.html)
DK (1) DK2044199T3 (cg-RX-API-DMAC7.html)
ES (1) ES2398593T3 (cg-RX-API-DMAC7.html)
GB (1) GB2437893A (cg-RX-API-DMAC7.html)
IL (1) IL196541A (cg-RX-API-DMAC7.html)
PL (1) PL2044199T3 (cg-RX-API-DMAC7.html)
WO (1) WO2008013692A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2244740A1 (en) 2008-02-19 2010-11-03 Celladon Corporation Compositions for enhanced uptake of viral vectors in the myocardium
PH12012501579A1 (en) * 2010-01-05 2012-10-22 Michael Aaron Vertical axis variable geometry wind energy collection system
US11583662B2 (en) 2016-04-18 2023-02-21 Sardocor Corp. Methods and compositions for consistent intracoronary administration of a biologic
KR20240093919A (ko) * 2017-04-14 2024-06-24 리젠엑스바이오 인크. 인간 뉴런 또는 신경교 세포에 의해 생성된 재조합 인간 이두로네이트-2 설파타제(ids)를 이용한 뮤코다당증 ii형의 치료
CN117241855A (zh) * 2021-02-22 2023-12-15 迪纳柯公司 肝脏的局部区域灌注

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5672344A (en) 1987-12-30 1997-09-30 The Regents Of The University Of Michigan Viral-mediated gene transfer system
US5302523A (en) 1989-06-21 1994-04-12 Zeneca Limited Transformation of plant cells
US5587308A (en) * 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
US6268213B1 (en) * 1992-06-03 2001-07-31 Richard Jude Samulski Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
US5478745A (en) * 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US5658785A (en) * 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
US6613749B1 (en) 1994-07-26 2003-09-02 Imperial College Innovations Limited Papovavirus pseudocapsids and use thereof for exogenous material transfer
US7745416B2 (en) * 1995-04-11 2010-06-29 The Regents Of The University Of California Method for in vivo regulation of cardiac muscle contractility
US5773289A (en) * 1995-06-06 1998-06-30 University Of Pittsburgh AAV directed targeted integration
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
US6162796A (en) * 1995-09-27 2000-12-19 The Rockefeller University Method for transferring genes to the heart using AAV vectors
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
EP0965336A1 (en) 1995-11-09 1999-12-22 Microbiological Research Authority Microencapsulated DNA for gene therapy
US20020001574A1 (en) 1995-12-13 2002-01-03 Jon A. Woiff Process of delivering a polynucleotide to a muscle cell via the vascular system
US5962313A (en) * 1996-01-18 1999-10-05 Avigen, Inc. Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
US5858351A (en) * 1996-01-18 1999-01-12 Avigen, Inc. Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
US5846528A (en) * 1996-01-18 1998-12-08 Avigen, Inc. Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
US20050095227A1 (en) * 1997-07-22 2005-05-05 The General Hospital Corporation Treating heart failure
US20090239940A1 (en) * 1997-07-22 2009-09-24 Del Monte Federica Treating heart failure and ventricular arrhythmias
US6566118B1 (en) * 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6410300B1 (en) * 1998-01-12 2002-06-25 The University Of North Carolina At Chapel Hill Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
EP1053025A2 (en) * 1998-02-11 2000-11-22 The Regents of the University of California Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
US6958147B1 (en) * 1998-10-26 2005-10-25 Licentia Ltd Use of VEGF-C to prevent restenosis
US6759237B1 (en) * 1998-11-05 2004-07-06 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
EP1139751A4 (en) * 1998-12-28 2003-03-19 Arch Dev Corp EFFICIENT AND STABLE -I (IN VIVO) GENE TRANSFER TO CARDIOMYCETS USING RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS
US6258595B1 (en) 1999-03-18 2001-07-10 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
HK1048593A1 (zh) * 1999-11-05 2003-04-11 The Regents Of The University Of California 用於通过体内基因输送治疗心血管疾病的技术和组合物
EP1228234A2 (en) * 2000-03-14 2002-08-07 Neurologix, Inc. Production of chimeric capsid vectors
US20020106381A1 (en) * 2000-06-13 2002-08-08 High Katherine A. Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
EP1324780A4 (en) * 2000-09-06 2005-06-22 Univ Johns Hopkins METHODS OF TREATING CARDIAC ARRHYTHMIA
CA2422078C (en) * 2000-09-11 2011-08-09 The Regents Of The University Of California High efficiency cardiac gene transfer
CN103589692B (zh) * 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
US20040106954A1 (en) * 2002-11-15 2004-06-03 Whitehurst Todd K. Treatment of congestive heart failure
US7781415B2 (en) * 2003-02-07 2010-08-24 Roche Madison Inc. Process for delivering sirna to cardiac muscle tissue
WO2005014835A1 (en) * 2003-07-17 2005-02-17 Bayerische Julius-Maximilians- Universität Würzburg Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis
US7291604B2 (en) * 2003-09-03 2007-11-06 The General Hospital Corporation Methods of treating restenosis
EP1691609A4 (en) * 2003-12-11 2006-11-29 Mirus Bio Corp RELEASE OF VIRUS VECTORS ANEXTRAVASAL PARENCHYM CELLS
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
CA2579519A1 (en) * 2004-09-09 2006-03-16 The General Hospital Corporation Modulating phosphatase activity in cardiac cells
WO2006089340A2 (en) * 2005-02-23 2006-08-31 V-Kardia Pty Ltd Polynucleotide delivery to cardiac tissue
US9375440B2 (en) * 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
EP2244740A1 (en) * 2008-02-19 2010-11-03 Celladon Corporation Compositions for enhanced uptake of viral vectors in the myocardium

Similar Documents

Publication Publication Date Title
Müller et al. Targeting the heart with gene therapy-optimized gene delivery methods
JP6417322B2 (ja) 遺伝子治療ベクターの広範な遺伝子送達
US20170209598A1 (en) Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
Gessler et al. Intravenous infusion of AAV for widespread gene delivery to the nervous system
US20220347319A1 (en) Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders
TW201840850A (zh) 腺相關病毒載體遞送肌肉特異性微小肌縮蛋白以治療肌肉萎縮症
CN106488984A (zh) 一种治疗周围神经病变以及运动神经元疾病的方法
KR20250012749A (ko) Aav 벡터를 사용한 b-세포 림프종 2-관련 안타노겐 3(bag3) 유전자 요법
Vekstein et al. Targeted delivery for cardiac regeneration: comparison of intra-coronary infusion and intra-myocardial injection in porcine hearts
Meloni et al. Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice
TW202302173A (zh) 肝之局部區域(loco-regional)灌流
US20170252462A1 (en) Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy
JP2024510108A5 (cg-RX-API-DMAC7.html)
EP4493703A2 (en) Methods and compositions for treating tmem43 related cardiomyopathy with a viral vector
JP2024529170A5 (cg-RX-API-DMAC7.html)
Su et al. AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid
US11634728B2 (en) Adeno-associated virus (AAV) vector having hybrid HGF gene introduced thereto
Bish et al. Adeno-associated virus vector delivery to the heart
Schirmer et al. Recombinant adeno‐associated virus vector for gene transfer to the transplanted rat heart
Bieber et al. Extracorporeal delivery of rAAV with metabolic exchange and oxygenation
JP2024545504A (ja) 発現増強のために選択されるコザック配列を含む組成物
Ziegler et al. AAV-mediated somatic gene editing for cardiac and skeletal muscle in a large animal model
Weber et al. Gene therapy for cardiovascular diseases
EP4646218A1 (en) Plakophilin-2 (pkp2) gene therapy using aav vector
CN118416257A (zh) Mif基因在制备治疗和/或预防心肌缺血损伤的药物中的应用、载体和药物